Abstract
Information on cost-effectiveness of multiple-risk-factor lifestyle interventions for Latinas with diabetes is lacking. The
aim of this paper is to evaluate costs and cost-effectiveness for ¡Viva Bien!, a randomized trial targeting Latinas with type
2 diabetes. We estimated 6-month costs; calculated incremental costs per behavioral, biologic, and quality-of-life change;
and performed sensitivity analyses from health plan and participant perspectives. Recruitment, intervention, and participant
costs were estimated at 45,896,432,433, and 179,697, respectively. This translates to4,634 in intervention costs per
¡Viva Bien! participant; $7,723 in both per unit reduction in hemoglobin A1c and per unit reduction in body mass index. Although
costs may be higher than interventions that address one risk factor, potential risks for longer-term health-care costs are
high for this at-risk group. Given the benefits of ¡Viva Bien!, cost reductions are recommended to enhance its efficiency,
adoption, and long-term maintenance without diluting its effectiveness.
aim of this paper is to evaluate costs and cost-effectiveness for ¡Viva Bien!, a randomized trial targeting Latinas with type
2 diabetes. We estimated 6-month costs; calculated incremental costs per behavioral, biologic, and quality-of-life change;
and performed sensitivity analyses from health plan and participant perspectives. Recruitment, intervention, and participant
costs were estimated at 45,896,432,433, and 179,697, respectively. This translates to4,634 in intervention costs per
¡Viva Bien! participant; $7,723 in both per unit reduction in hemoglobin A1c and per unit reduction in body mass index. Although
costs may be higher than interventions that address one risk factor, potential risks for longer-term health-care costs are
high for this at-risk group. Given the benefits of ¡Viva Bien!, cost reductions are recommended to enhance its efficiency,
adoption, and long-term maintenance without diluting its effectiveness.
- Content Type Journal Article
- Pages 1-9
- DOI 10.1007/s13142-011-0037-z
- Authors
- Debra P Ritzwoller, Institute for Health Research, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA
- Anna S Sukhanova, Institute for Health Research, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA
- Russell E Glasgow, Institute for Health Research, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA
- Lisa A Strycker, Oregon Research Institute, Eugene, OR, USA
- Diane K King, Institute for Health Research, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA
- Bridget Gaglio, Institute for Health Research, Kaiser Permanente Colorado, P.O. Box 378066, Denver, CO 80237-8066, USA
- Deborah J Toobert, Oregon Research Institute, Eugene, OR, USA
- Journal Translational Behavioral Medicine
- Online ISSN 1613-9860
- Print ISSN 1869-6716